A prospective, non-interventional study (NIS) of Trastuzumab in german HER2+ metastatic breast cancer patients.
Phase of Trial: Phase IV
Latest Information Update: 10 Feb 2016
At a glance
- Drugs Trastuzumab (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 10 Feb 2016 New trial record
- 12 Dec 2015 Interim results (n=230) presented at the 38th Annual San Antonio Breast Cancer Symposium.
- 12 Dec 2015 Results (n=1042) presented at the 38th Annual San Antonio Breast Cancer Symposium.